2004
DOI: 10.1016/j.neuropharm.2003.11.023
|View full text |Cite
|
Sign up to set email alerts
|

Trichloroethanol enhances the activity of recombinant human TREK-1 and TRAAK channels

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
26
1

Year Published

2005
2005
2016
2016

Publication Types

Select...
7
1

Relationship

2
6

Authors

Journals

citations
Cited by 23 publications
(28 citation statements)
references
References 24 publications
1
26
1
Order By: Relevance
“…hTREK1, when expressed in infected HEK 293 cells, formed functional channels with kinetics similar to that described previously (Harinath and Sikdar, 2004). In physiological K ϩ gradient, an outwardly rectifying, noninactivating, time-dependent current progressively developed upon depolarization, which was absent in uninfected cells and Ad-GFP-infected cells (Supplemental Fig.…”
Section: Resultssupporting
confidence: 72%
See 1 more Smart Citation
“…hTREK1, when expressed in infected HEK 293 cells, formed functional channels with kinetics similar to that described previously (Harinath and Sikdar, 2004). In physiological K ϩ gradient, an outwardly rectifying, noninactivating, time-dependent current progressively developed upon depolarization, which was absent in uninfected cells and Ad-GFP-infected cells (Supplemental Fig.…”
Section: Resultssupporting
confidence: 72%
“…The AdEasy-1 adenoviral vector system, including the pAdTrack-cytomegalovirus (shuttle vector), pAdEasy-1, and the electrocompetent cells of BJ5183 strain of Escherichia coli, was a generous gift from Prof. Bert Vogelstein (John Hopkins Oncology Center, Baltimore, MD). The Cterminal deletion mutants of hTREK1 (⌬89 and ⌬119 hTREK1) were constructed by PCR mutagenesis as described previously (Harinath and Sikdar, 2004), and the S348A mutant of hTREK1 was a generous gift from Prof. Steve A. N. Goldstein (Yale University Medical School). The other site-directed mutageneses such as the S348D, S366A, and Y352A/F355A were performed with a QuikChange kit (Stratagene, La Jolla, CA), and mutations were verified by DNA sequencing that is illustrated in Supplemental Fig.…”
Section: Methodsmentioning
confidence: 99%
“…Because of the localization of TREK-1 in the CNS, and its high sensitivity to clinically relevant concentrations of the volatile anesthetics, it has been proposed that TREK-1 is the best candidate to have an important role in anesthesia (268). In support of this assumption, further anesthetics, which do not influence GABA A receptors, chloral hydrate (127), N 2 O, xenon, and cyclopropane (121) were also found to activate TREK-1, but not TASK-1. Even more convincing evidence for the involvement of TREK-1 in the anesthetic action was provided by experiments on a knockout model.…”
Section: General Anesthesiamentioning
confidence: 99%
“…In our previous report we described the stable expression of human TREK-1 in CHO cells (Harinath and Sikdar, 2004). We utilized the same cell-line for experiments in the present study.…”
Section: Resultsmentioning
confidence: 99%
“…A stable cell-line of CHO cells expressing human TREK-1 channels (CHO TREK-1 ; Harinath and Sikdar, 2004) was maintained in DMEM-F-12 HAM supplemented with 10% fetal bovine serum (v/v), 1% antibiotic-antimycotic (Sigma) and gentamicin (50 g) (Sigma) in a humidified incubator with an atmosphere of 5% CO 2 . When the cells were confluent, they were split and plated onto 35 mm culture dishes.…”
Section: Cell Culture and Transfectionmentioning
confidence: 99%